174 related articles for article (PubMed ID: 26659117)
1. Lifestyle Risk Factors Among People Who Have Had Cancer Genetic Testing.
Quillin JM
J Genet Couns; 2016 Oct; 25(5):957-64. PubMed ID: 26659117
[TBL] [Abstract][Full Text] [Related]
2. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C
Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829
[TBL] [Abstract][Full Text] [Related]
3. Can we test for hereditary cancer at 18 years when we start surveillance at 25? Patient reported outcomes.
Sie AS; Prins JB; Spruijt L; Kets CM; Hoogerbrugge N
Fam Cancer; 2013 Dec; 12(4):675-82. PubMed ID: 23604858
[TBL] [Abstract][Full Text] [Related]
4. Genetic Counselors' Experiences Regarding Communication of Reproductive Risks with Autosomal Recessive Conditions found on Cancer Panels.
Mets S; Tryon R; Veach PM; Zierhut HA
J Genet Couns; 2016 Apr; 25(2):359-72. PubMed ID: 26454646
[TBL] [Abstract][Full Text] [Related]
5. Identification of germline genetic mutations in patients with pancreatic cancer.
Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
[TBL] [Abstract][Full Text] [Related]
6. Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial.
Kiechle M; Engel C; Berling A; Hebestreit K; Bischoff SC; Dukatz R; Siniatchkin M; Pfeifer K; Grill S; Yahiaoui-Doktor M; Kirsch E; Niederberger U; Enders U; Löffler M; Meindl A; Rhiem K; Schmutzler R; Erickson N; Halle M
Trials; 2016 Jul; 17():368. PubMed ID: 27473440
[TBL] [Abstract][Full Text] [Related]
7. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
8. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
[TBL] [Abstract][Full Text] [Related]
9. Genetic testing by cancer site: ovary.
Weissman SM; Weiss SM; Newlin AC
Cancer J; 2012; 18(4):320-7. PubMed ID: 22846732
[TBL] [Abstract][Full Text] [Related]
10. Behavioral risk factors among women presenting for genetic testing.
Emmons KM; Kalkbrenner KJ; Klar N; Light T; Schneider KA; Garber JE
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):89-94. PubMed ID: 10667468
[TBL] [Abstract][Full Text] [Related]
11. Current and future role of genetic screening in gynecologic malignancies.
Ring KL; Garcia C; Thomas MH; Modesitt SC
Am J Obstet Gynecol; 2017 Nov; 217(5):512-521. PubMed ID: 28411145
[TBL] [Abstract][Full Text] [Related]
12. Practical aspects of genetic counseling in breast cancer: lights and shadows.
Christinat A; Pagani O
Breast; 2013 Aug; 22(4):375-82. PubMed ID: 23673076
[TBL] [Abstract][Full Text] [Related]
13. Genetic testing by cancer site: breast.
Shannon KM; Chittenden A
Cancer J; 2012; 18(4):310-9. PubMed ID: 22846731
[TBL] [Abstract][Full Text] [Related]
14. Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.
Lheureux S; Karakasis K; Harter P; Scott C; Bacon M; Bryce J; Le Fur N; Pujade-Lauraine E; Oza AM
Gynecol Oncol; 2016 Jan; 140(1):90-4. PubMed ID: 26475959
[TBL] [Abstract][Full Text] [Related]
15. Reproductive Endocrinologists' Utilization of Genetic Counselors for Oncofertility and Preimplantation Genetic Diagnosis (PGD) Treatment of BRCA1/2 Mutation Carriers.
Goetsch AL; Wicklund C; Clayman ML; Woodruff TK
J Genet Couns; 2016 Jun; 25(3):561-71. PubMed ID: 26567039
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Factors for Distress After Genetic Testing for Hereditary Cancer.
Voorwinden JS; Jaspers JP
J Genet Couns; 2016 Jun; 25(3):495-503. PubMed ID: 26475052
[TBL] [Abstract][Full Text] [Related]
17. Hereditary breast cancer and genetic counseling in young women.
Brunet J
Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():7-9. PubMed ID: 20711663
[No Abstract] [Full Text] [Related]
18. Genetic testing and prevention of hereditary cancer at the MMCI--over 10 years of experience.
Foretova L; Petrakova K; Palacova M; Kalabova R; Svoboda M; Navratilova M; Schneiderova M; Bolcak K; Krejci E; Drazan L; Mikova M; Hazova J; Vasickova P; Machackova E
Klin Onkol; 2010; 23(6):388-400. PubMed ID: 21348412
[TBL] [Abstract][Full Text] [Related]
19. Patients' Attitudes Towards Disclosure of Genetic Test Results to Family Members: The Impact of Patients' Sociodemographic Background and Counseling Experience.
Gilbar R; Shalev S; Spiegel R; Pras E; Berkenstadt M; Sagi M; Ben-Yehuda A; Mor P; Perry S; Zaccai TF; Borochowitz Z; Barnoy S
J Genet Couns; 2016 Apr; 25(2):314-24. PubMed ID: 26371363
[TBL] [Abstract][Full Text] [Related]
20. Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors.
Trepanier A; Ahrens M; McKinnon W; Peters J; Stopfer J; Grumet SC; Manley S; Culver JO; Acton R; Larsen-Haidle J; Correia LA; Bennett R; Pettersen B; Ferlita TD; Costalas JW; Hunt K; Donlon S; Skrzynia C; Farrell C; Callif-Daley F; Vockley CW;
J Genet Couns; 2004 Apr; 13(2):83-114. PubMed ID: 15604628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
